What is Syndax Pharmaceuticals's interest coverage?

Syndax Pharmaceuticals (SNDX) reported interest coverage of -55,882.3× in Q1 2026.

What is the long-term trend for Syndax Pharmaceuticals's interest coverage?

Over 4 years (2020 to 2025), Syndax Pharmaceuticals's interest coverage has grown at a 522.5% compound annual growth rate (CAGR), from -30.3× to -45,514×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Syndax Pharmaceuticals SNDX Interest coverage

Interest coverage at other companies

IncyteINCY

689.3×+620×

SELLAS Life Sciences Group, Inc.SLS

-15.7×-5.6×

Viridian Therapeutics, Inc.VRDN

-49.3×-20.0×

Nuvation BioNUVB

-7.4×-3.7×

Arcus BiosciencesRCUS

-39.8×-15.5×

Enliven TherapeuticsELVN

-6.8×-0.5×

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Calculated from Syndax Pharmaceuticals’s reported figures.

ebit/interest expense=-55,882.3×

Based on trailing twelve months.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's interest coverage?: Syndax Pharmaceuticals (SNDX) reported interest coverage of -55,882.3× in Q1 2026.
What is the long-term trend for Syndax Pharmaceuticals's interest coverage?: Over 4 years (2020 to 2025), Syndax Pharmaceuticals's interest coverage has grown at a 522.5% compound annual growth rate (CAGR), from -30.3× to -45,514×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.